Education
About Us
Working with TipRanks
Follow Us
PharmaCielo (TSE:PCLO)
:PCLO
PCLO Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.03 - C$0.23
Previous CloseN/A
Volume2.00K
Average Volume (3M)51.35K
Market Cap
$7.69M
Enterprise ValueC$31.30M
Total Cash (Recent Filing)$147.94K
Total Debt (Recent Filing)C$20.52M
Price to Earnings (P/E)―
Beta>-0.01
Next Earnings
Aug 15, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding187,828,800
10 Day Avg. Volume73,356
30 Day Avg. Volume51,349
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)-1.40
Price to Sales (P/S)0.00
P/FCF Ratio-5.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PharmaCielo News
PremiumCompany Announcements
PharmaCielo Issues Shares to Settle Debts and Interest
PremiumCompany Announcements
PharmaCielo’s Revenue Soars with Strategic Growth
PremiumCompany Announcements
PharmaCielo Extends Warrant Expiry to Boost Market Position
PremiumCompany Announcements
PharmaCielo Shifts Fiscal Year-End and Names New Auditor
PremiumCompany Announcements
PharmaCielo’s Financial Health Improves in Q2 2024
PremiumCompany Announcements
PharmaCielo Nears Trading Reinstatement and Secures Funding
PremiumCompany Announcements
PharmaCielo Poised for TSXV Trading ReinstatementOptions Prices
Currently, No data available
---
Ownership Overview
7.76% Insiders
4.39%
Mutual Funds
<0.01% Other Institutional Investors
92.05% Public Companies and
Individual Investors
PCLO FAQ
What was PharmaCielo’s price range in the past 12 months?
PharmaCielo lowest stock price was C$0.03 and its highest was C$0.23 in the past 12 months.
What is PharmaCielo’s market cap?
PharmaCielo’s market cap is $7.69M.
When is PharmaCielo’s upcoming earnings report date?
PharmaCielo’s upcoming earnings report date is Aug 15, 2025 which is in 19 days.
How were PharmaCielo’s earnings last quarter?
Currently, no data Available
Is PharmaCielo overvalued?
According to Wall Street analysts PharmaCielo’s price is currently Overvalued.
Does PharmaCielo pay dividends?
PharmaCielo does not currently pay dividends.
What is PharmaCielo’s EPS estimate?
PharmaCielo’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PharmaCielo have?
PharmaCielo has 187,828,800 shares outstanding.
What happened to PharmaCielo’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PharmaCielo?
Currently, no hedge funds are holding shares in TSE:PCLO
Company Description
PharmaCielo
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. The company has a strategic alliance with AssuredTrans Inc. PharmaCielo Ltd. is headquartered in Toronto, Canada.
Technical Analysis
Khiron Life Sciences
―
Sproutly Canada
―
CordovaCann
―
IM Cannabis Corp
―
CanadaBis Capital
―